Estée Lauder
No proof required
Up to $5,000
Claims opening soon
A
Aggrenox
A $54 million settlement was reached for the Aggrenox generic drug delay antitrust class action.
ClosedUnited States-wideClaim status: Claim window closedPayout: Up to $175.86No longer claimable
About this settlement
Settlement for consumers who purchased Aggrenox and were affected by alleged antitrust delays in generic drug availability.
This class action settlement resolves claims related to delays in generic versions of the drug Aggrenox, providing compensation to eligible purchasers.
Who qualifies
- Individuals who purchased Aggrenox within the last eight years.
- Claimants affected by the generic drug delay.
Up to $175.86
Claim status: Claim window closed
Audible
No proof required
Compensation pending
Claims opening soon
Government of Canada
Proof required
Up to $200,000
644 days left
Meta (Facebook)
No proof required
Up to $90
Claims opening soon
Ticketmaster
No proof required
Compensation pending
Claims opening soon
Apple
No proof required
Up to $100
Claims opening soon